Skip to main content

$0.009 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
3 July 2025 at 9:19am
Register to track CPH and receive email alerts.
Subject
CPH Ann: Creso Pharma to Develop New Hemp-Based Lozenge Product

CPH Ann: Halucenex Update

CPH Ann: Proposed issue of securities - CPH

CPH Ann: Investor Presentation - Sierra Sage Acquisition

CPH Ann: Creso to enter US CBD Market through Sierra Sage Acquisition

CPH Ann: Quarterly Activities/Appendix 4C Cash Flow Report

CPH Ann: Application for quotation of securities - CPH

CPH Ann: Application for quotation of securities - CPH

CPH Ann: Halucenex Lodges Clinical Trial Authorisation

CPH Ann: Initial Director's Interest Notice x3

CPH Ann: Executive Director Remuneration

CPH Ann: Proposed issue of securities - CPH

CPH Ann: Creso Pharma Announces Three New Board Appointments

CPH Ann: Halucenex Update

CPH Ann: Release of Shares from Voluntary Escrow

CPH Ann: Application for quotation of securities - CPH

CPH Ann: Change of Registry Address

CPH Ann: Conversion of Performance Shares

CPH Ann: Application for quotation of securities - CPH

CPH Ann: Application for quotation of securities - CPH

CPH Ann: Mernova on track for quarter-on-quarter revenue growth

CPH Ann: Halucenex Awarded Dealer's License Amendment

CPH Ann: Trading Halt

CPH Article: EverBlu’s Blumenthal steps down at Creso over ASIC trading probe

CPH Article: Creso Pharma embroiled in ASIC investigation

CPH Ann: Update on Price and Volume Query Response

CPH Ann: Trading Halt

CPH Ann: Pause in Trading

CPH Ann: Application for quotation of securities - CPH

CPH Ann: Notification of cessation of securities - CPH

CPH Article: Creso Pharma yet to verify relation to Everblu raids

CPH Ann: Response to ASX Price and Volume Query

CPH Article: Creso Pharma in eye of EverBlu storm

CPH Ann: Trading Halt

CPH Ann: Pause in Trading

CPH Ann: Creso Pharma Completes Integration of ImpACTIVE Assets

CPH Ann: Creso Pharma Anticipates Increasing Q4 2021 Swiss Revenue

CPH Ann: Dr Brian Walker Resigns as Strategic Consultant

CPH Ann: Change of Director's Interest Notice x 3

CPH Ann: Halucenex Receives Positive USP 61 and USP 62 Results

CPH Ann: Notification regarding unquoted securities - CPH

CPH Ann: Proposed issue of securities - CPH

CPH Ann: Appointment of Hon. Dr Brian Walker as Strategic Advisor

CPH Ann: Top 20 Holders

CPH Ann: Distribution Schedule

CPH Ann: Application for quotation of securities - CPH

CPH Ann: Creso Pharma to Enter Swiss Medicinal Cannabis Market

CPH Ann: Quarterly Activities/Appendix 4C Cash Flow Report

CPH Ann: Application for quotation of securities - CPH

CPH Ann: Secondary Trading Notice

Register to track CPH and receive email alerts.

Similar Companies

CAN
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL